Research and Markets: Company Reports - China Biotics (CHBT.NASDAQ).
This report analyses China Biotics (CHBT.NASDAQ). This issue focuses on China Biotics' position in the domestic probiotics market. In particular, due diligence was carried out on work distribution network, production capacity, customer base, revenue breakdown etc.
This report provides insight on the following key issues:
* China Biotics' distribution channels for its retail products.
* China Biotics' Shanghai production facility.
* Other issues regarding China Biotic
* Conclusion on the stock: whether to buy, hold or sell.
Anyone who has an interest in USA listed China stocks needs to buy this report now and see the value the research gives you (and your bottom line).
China-Biotics, Inc. engages in the research, development, production, marketing, and distribution of probiotics products in the People's Republic of China. Its products contain live microbial food supplements, which beneficially affect the host by improving its intestinal microbial balance. The company serves individual customers; and institutional customers, such as dairy manufacturers, animal feed manufacturers, pharmaceutical companies, and food companies. It distributes its retail products directly, as well as through distributors in the greater Shanghai area under the Shining brand. As of March 31, 2010, the company had 111 Shining branded outlets in Shanghai and 12 other cities in China. China-Biotics, Inc. was founded in 1999 and is based in Pudong, the Peoples Republic of China. (Source: Yahoo Finance!)
Sector: Healthcare Industry: Drug Manufacturers - Other
Key Topics Covered:
Section I - Corporate Overview
Section II - Revenue Breakdown
Section III - Main Issues
Section IV - Conclusion
For more information visit http://www.researchandmarkets.com/research/850bb9/company_reports
|Printer friendly Cite/link Email Feedback|
|Article Type:||Company overview|
|Date:||Apr 6, 2011|
|Previous Article:||MercuryGate Announces FreightFriend.|
|Next Article:||Rhyne Valley Wines Earn Widespread International Acclaim, Reaching Record-Breaking Popularity.|